Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer: Final Analysis of a Phase 2 Trial. - Bryant, J.M.; Sandoval, M.L.; Putney, R.; Caslini, C.; Katende, E.; Fink, A.; Trivedi, P.; Naqvi, S.M.; Kim, Y.; Zhang, J.; Park, J.; Serna, A.; et al. (International Journal of Radiation Oncology, Biology, Physics, 2024)